CNA Financial’s Allergan plc AGN Stock Holding History

CNA Financial’s Portfolio AGN Stock Details AGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q4	–	Sell	-12,670	Closed	-$2.6M	–	170
2017 Q3	$2.6M	Buy	+12,670	New	+$2.95M	0.65%	49

Other funds holding AGN

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Baupost Group Boston, Massachusetts $5.12B AUM 15.99% 1-Year Est. Return

CNA Financial's AGN Position: Q4 2017 in Review

CNA Financial sold out of Allergan plc (AGN) in Q4 2017, closing a stake of 12,670 shares — an estimated $2.6M sold.

CNA Financial first reported a position in AGN in Q3 2017 and held it in 1 quarter. The position peaked at $2.6M in Q3 2017. 1,048 funds tracked by Wall St. Rank hold AGN as of Q4 2017.

CNA Financial reported no remaining Allergan plc position as of Q4 2017 after selling out during the quarter.
CNA Financial sold 12,670 Allergan plc shares in Q4 2017, an estimated $2.6M.
CNA Financial first reported a position in Allergan plc in Q3 2017 and held it in 1 quarter.
CNA Financial's Allergan plc position peaked at $2.6M in Q3 2017.
1,048 funds tracked by Wall St. Rank held Allergan plc as of Q4 2017.

Based on CNA Financial's 13F filing for Q4 2017, filed 8 Feb 2018.